PFIZER INC Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) of -$230.00 million for the 3-month period ending 2011-10-02, per its 10-Q filed 2011-11-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease · last filed 2011-11-10
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-10-02 was -$230.00M.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-07-03 was $11.00M.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-04-03 was -$135.00M, a 200.75% decline year-over-year.
- PFIZER INC other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2010-10-03 was -$59.00M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 9 month |
|---|---|---|---|
| 2011-10-02 | -$230.00M 10-Q · filed 2011-11-10 | -$219.00M derived: sum of 2 quarters · filed 2011-11-10 | -$354.00M 10-Q · filed 2011-11-10 |
| 2011-07-03 | $11.00M 10-Q · filed 2011-08-11 | -$124.00M 10-Q · filed 2011-08-11 | |
| 2011-04-03 | -$135.00M 10-Q · filed 2011-05-12 | ||
| 2010-10-03 | -$59.00M 10-Q · filed 2011-11-10 | -$434.00M derived: sum of 2 quarters · filed 2011-11-10 | -$300.00M 10-Q · filed 2011-11-10 |
| 2010-07-04 | -$375.00M 10-Q · filed 2011-08-11 | -$241.00M 10-Q · filed 2011-08-11 | |
| 2010-04-04 | $134.00M 10-Q · filed 2011-05-12 | ||
| 2009-09-27 | -$43.00M 10-Q · filed 2010-11-12 | -$187.00M derived: sum of 2 quarters · filed 2010-11-12 | -$210.00M 10-Q · filed 2010-11-12 |
| 2009-06-28 | -$144.00M 10-Q · filed 2010-08-12 | -$167.00M 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |